ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "cytokines"

  • Abstract Number: 1412 • 2017 ACR/ARHP Annual Meeting

    Yra-1909 suppresses Production of Pro-Inflammatory Mediators and MMPs through Downregulating Akt, p38, JNK and NF-κb Activation in Rheumatoid Arthritis Fibroblast-like Synoviocytes

    Hyun Jung Yoo1,2, Jeong Yeon Kim1, Shin Eui Kang1, Ji Seok Yoo3, Yong Nam Lee3, Dong Goo Lee3, Ji Soo Park1, Eun Bong Lee4, Eun Young Lee4 and Yeong Wook Song2,5, 1Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea, Seoul, Korea, Republic of (South), 2Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, Seoul, Korea, Republic of (South), 3Central R&D Institute, Yungjin Pharm Co., Ltd., Suwon, Korea, Suwon, Korea, Republic of (South), 4Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, Republic of (South), 5Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine, Seoul National University, Seoul, Korea, Republic of (South)

    Background/Purpose: Rheumatoid arthritis (RA) is characterized by hyperplastic synovial pannus tissue, which mediates destruction of cartilage and bone. Fibroblast-like synoviocyte (FLS) are a key component…
  • Abstract Number: 2574 • 2017 ACR/ARHP Annual Meeting

    Interleukin-33 Ameliorates Murine Lupus Via Induction of Regulatory T Cells and M2 Macrophage Polarisation

    Mo Yin Mok1, Ka Sin Law2, Wing Yin Kong1, Ge Liu1, Wallace Lau2, C Luo2, FP Huang3, GC Chan4 and Kwok Wah Chan3, 1Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, Hong Kong, 2Department of Medicine, Queen Mary Hospital, Hong Kong, Hong Kong, 3Department of Pathology, University of Hong Kong, Hong Kong, Hong Kong, 4Department of Paediatrics, University of Hong Kong, Hong Kong, Hong Kong

    Background/Purpose: The levels of IL-33, a Th2 promoting cytokine, and the soluble form of its receptor ST2 were reported to be elevated in serum of…
  • Abstract Number: 71 • 2017 ACR/ARHP Annual Meeting

    The Critical Role of Interleukin-33 in Promoting Angiogenesis and Regulates Inflammation through Mast Cells in Takayasu Arteritis

    Anne-Claire Desbois1, Patrice Cacoub2, Aurélie LEROYER3, Edwige Tellier4, Marlène Garrido5, Anna Maciejewski-Duval6, Cloé Comarmond7, Stéphane Barete6, Michel Arock6, Patrick Bruneval8, Jean-Marie Launay9, Pierre Fouret10, Ulrich Blank11, Michelle Rosenzwajg6, David Klatzman12, Mohamed Jarraya13, Philippe Cluzel14, Fabien Koskas15, Gilles Kaplanski16 and David Saadoun17, 1Hôpital Pitié-Salpêtrière, Internal Medicine and Clinical Immunology, Paris, France, 2Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Pitié-Salpêtrière, Paris, France, 3Faculté de Pharmacie, Marseille, France, 4Université Marseille, Marseille, France, 5I3 laboratory, Pitié-Salpétrière, Paris, France, 6GHPS, Paris, France, 7DHU 2iB Internal Medicine Referal Center for Autoimmune diseases Pitie Hospital, Paris, France, 8HEGP, Paris, France, 9Hôpital lariboisière, Paris, France, 10Hôpital La Pitié Salpétrière, Paris, France, 11Hôpital Bichat, Paris, France, 12UPMC Université Paris 06, UMR 7211, Paris, France, 13Hôpital Saint Louis, Paris, France, 14Department of cardiovascular imagery, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Pitié Salpétrière, 83 Boulevard de l'Hôpital, 75013, Paris, France., Paris, France, 15Department of vascular surgery, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France, 16Aix-Marseille Université - Internal Medicine hopital conception - F-13000 Marseilles, Marseille, France, 17Sorbonne Universités, UPMC Univ Paris 06, UMR 7211, and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), F-75005, Paris, France; INSERM, UMR_S 959, F-75013, Paris, France; CNRS, FRE3632, F-75005, Paris, France; AP-HP, Groupe Hospitalier, Paris, France

    Background/Purpose: Large vessel vasculitis (LVV) include Takayasu arteritis (TA) and giant cell arteritis (GCA). Arterial lesions in LVV result from chronic inflammation and neoangiogenesis. IL-33,…
  • Abstract Number: 1413 • 2017 ACR/ARHP Annual Meeting

    Cytokine-Induced Aire Activity in Rheumatoid Arthritis Fibroblast-like Synoviocytes Regulates Expression of Interferon-γ Response Genes

    Beatrice Bergström1, Christina Lundqvist1, Hans Carlsten1, Olov Ekwall2 and Anna-Karin Hultgård Ekwall1, 1Rheumatology and Inflammation Research, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden, 2Dept. of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy University of Gothenburg, Göteborg, Sweden

    Background/Purpose: AIRE is a transcriptional regulator of tissue specific antigens in medullary thymic epithelial cells (mTEC). AIRE orchestrates the negative selection of self-reactive T cells…
  • Abstract Number: 2596 • 2017 ACR/ARHP Annual Meeting

    Hydroxychloroquine Use Is Associated with Decreased Dendritic Cell Activation and Thrombolytic Factors in SLE Patients

    Samantha Slight-Webb1, Rufei Lu2, Hua Chen1, Holden T. Maecker3, Paul J. Utz4, Joel M. Guthridge5 and Judith A. James6, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 4Medicine, Stanford University School of Medicine, Stanford, CA, 5Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: The antimalarial drug hydroxychloroquine (HCQ) has been used for decades to treat various rheumatic diseases including systemic lupus erythematosus (SLE). The efficacy of HCQ…
  • Abstract Number: 73 • 2017 ACR/ARHP Annual Meeting

    Regulation of Th17 Cell Responses By IL-25

    Sophie Archer, Ash Maroof, Meryn Griffiths and Stevan Shaw, UCB Pharma, Slough, United Kingdom

    Background/Purpose: IL-17A is a Th17 proinflammatory cytokine that contributes to the pathophysiology of several immune-mediated inflammatory diseases including PsA; while previously underestimated, there is increasing…
  • Abstract Number: 1672 • 2017 ACR/ARHP Annual Meeting

    Cytokines and Autoantibody Cluster-Interaction in Systemic Lupus Erythematosus. a Systems Medicine Approach

    Julian Barahona-Correa, Yovana Pacheco, Diana M. Monsalve, Manuel Rojas, Yhojan Rodríguez, Juliana Saavedra, Mónica Rodríguez-Jiménez, Ruben Mantilla, Carolina Ramírez-Santana, Nicolás Molano-González and Juan-Manuel Anaya, Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia

    Background/Purpose: Evidence supports the existence of different sub-phenotypes and the pivotal role of cytokines and autoantibodies in systemic lupus erythematosus (SLE). Cytokines interact in a…
  • Abstract Number: 2598 • 2017 ACR/ARHP Annual Meeting

    The Effects of Tai Chi on Inflammatory Mediator Secretion in Systemic Lupus Erythematosus

    Juliette Yedimenko1, Evelyn Thomas2, Brian Snoad3, Juhi Sharma2, Misha Mobeen2, Holly Steigelman1, Alexa Meara4, Giancarlo R. Valiente5, Stacy P. Ardoin6, Nicole Powell7, John Sheridan7, Wael Jarjour8 and Nicholas A. Young3, 1The Ohio State University Wexner Medical Center, Columbus, OH, 2The Ohio State University, Columbus, OH, 3Department of Internal Medicine, Division of Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 4Internal Medicine/Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 5Rheumatology & Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 6Pediatric & Adult Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 7Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, 8Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: Exercise and psychological stress have been shown to produce opposite effects on immunomodulation.  Prior studies in patients with Systemic Lupus Erythematosus (SLE) have demonstrated…
  • Abstract Number: 9 • 2017 Pediatric Rheumatology Symposium

    Biologically-Based Approach for Classifying Chronic Childhood Arthritis

    Elham Rezaei1, Daniel Hogan2, Brett Trost2, Anthony Kusalik2, Susanne Benseler3, Gilles Boire4, David A. Cabral5, Bonnie Cameron6, Sarah Campillo7, Gaëlle Chédeville8, Paul Dancey9, Ciarán M. Duffy10, Karen N Watanabe Duffy11, Janet Ellsworth12, Simon Eng13, Brian M. Feldman14, John Gordon2, Jaime Guzman15, Kristin Houghton16, Adam Huber17, Quaid Morris13, Bianca Lang18, Deborah M. Levy19, Loren Matheson20, Kiem Oen21, Ross Petty22, Suzanne Ramsey23, Johannes Roth24, Dax Rumsey25, Claire Saint-Cyr26, Rayfel Schneider27, Rosie Scuccimarri28, Earl Silverman19, Lynn R. Spiegel29, Elizabeth Stringer18, Shirley M.L. Tse30, Lori Tucker31, Rae S.M. Yeung32 and Alan Rosenberg1, 1Pediatrics, University of Saskatchewan, Saskatoon, SK, Canada, 2University of Saskatchewan, Saskatoon, SK, Canada, 3Pediatric Rheumatology, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada, 4Rheumatology Division, CHUS - Sherbrooke University, Sherbrooke, QC, Canada, 5Pediatrics/Rm K4-121, BC Children's Hospital, Vancouver, BC, Canada, 6The Hospital for Sick Children, Toronto, ON, Canada, 7Montreal Children's Hospital, Montreal, QC, Canada, 8Rheumatology, McGill University, Montreal, QC, Canada, 9Pediatrics, Janeway Children's Hospital, St. John's, NL, Canada, 10Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 11Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 12University of Alberta, Edmonton, AB, Canada, 13University of Toronto, Toronto, ON, Canada, 14Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 15Rheumatology, BC Children's Hospital, Vancouver, BC, Canada, 16Rheumatology/Pediatrics, British Columbia Childrens Hos, Vancouver, BC, Canada, 17IWK Health Centre, Halifax, NS, Canada, 18Dalhousie University, Halifax, NS, Canada, 19Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 20University of Saskatchewan, Ottawa, ON, Canada, 21University of Manitoba, Winnipeg, MB, Canada, 22Pediatric Rheumatology, Division of Rheumatology, BC Children's Hospital, Vancouver, BC, Canada, 23Pediatric Rheumatology, IWK Health Centre, Halifax, NS, Canada, 24Pediatric Rheumatology, Children's Hospital Eastern On, Ottawa, ON, Canada, 25Stollery Children's Hospital, Edmonton, AB, Canada, 26Pediatrics, CHU Sainte-Justine, Montreal, QC, Canada, 27Division of Rheumatology, Hospital for Sick Children, Toronto, ON, Canada, 28Division of Pediatric Rheumatology, Montreal Children's Hospital/McGill University Health Centre, Montreal, QC, Canada, 29Rheumatology/Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada, 30Rheumatology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, 31Pediatric Rheum/Rm K4-120, BC Childrens Hospital, Vancouver, BC, Canada, 32Paediatrics, Immunology and Medical Science, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Juvenile Idiopathic Arthritis (JIA) comprises a heterogeneous group of conditions that share chronic arthritis as a common characteristic. International uniformity in classifying JIA, based…
  • Abstract Number: 15L • 2016 ACR/ARHP Annual Meeting

    Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis vulgaris and Normalizes Skin Pathology Via Concurrent Regulation of IL-17 and IL-10 Levels

    Alexandra Zanin-Zhorov1, Jonathan Weiss1, Alissa Trzeciak1, Carmen Arencibia1, Seetharam Polimera1, Wei Chen1, Jingya Zhang1, Melanie Nyuydzefe1, Judilyn Fuentes-Duculan2, Kathleen Bonifacio2, Norma Kunjravia2, Inna Cueto2, Mark Berger1, James Krueger2, Samuel Waksal1 and John Ryan1, 1Kadmon, New York, NY, 2Rockefeller University, New York, NY

    Background/Purpose: Rho-associated kinase 2 (ROCK2) was shown to be implicated in regulation of autoimmunity in mice and humans1. Previous findings demonstrated that oral administration of…
  • Abstract Number: 1247 • 2016 ACR/ARHP Annual Meeting

    Diagnostic Modeling of Rheumatoid Arthritis in Oklahoma Tribal Members Using Soluble Mediators

    Lucas Adams1, Carla J. Guthridge1, Tim Gross1, Hua Chen1, Krista M. Bean1, Virginia C. Roberts1, Julie M. Robertson2, Melissa E. Munroe1, Joel M. Guthridge3, Roger Montgomery4, M. Sohail Khan4, Fabio Mota5, Michael Peercy6, Bobby Saunkeah7 and Judith A. James8,9, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Acelity, San Antonio, TX, 3Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Cherokee Nation Health Services, Tahlequah, OK, 5Chickasaw Nation Medical Center, Ada, OK, 6Epidemiology, Chickasaw Nation Department of Health, Ada, OK, 7Chickasaw Nation Department of Health, Ada, OK, 8Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 9Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Diagnosis of RA is difficult in American Indian (AI) patients who often have atypical autoantibodies (e.g. ANA) with erosive arthritis. Soluble mediators may serve…
  • Abstract Number: 2154 • 2016 ACR/ARHP Annual Meeting

    Novel Pathogenic Functions of IL-11 on RA Joint Fibroblasts and Endothelial Cells

    Hatem A. Elshabrawy1,2, Abdul B. Essani1,2, Zhenlong Chen1, Michael Volin3, Iain B McInnes4, Seung-jae Kim2,5 and Shiva Shahrara2,6, 1Medicine, University of Illinois at Chicago, Chicago, IL, 2Jesse Brown VA Medical Center, Chicago, IL, 3Midwestern University, Downers Grove, IL, 4University of Glasgow, Glasgow, Great Britain, 5University of Illinois at Chicago, Chicago, IL, 6Medicine/Rheumatology, University of Illinois at Chicago, Chicago, IL

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting 2.5 millions of Americans. Several cytokines are involved in RA pathogenesis and may serve as…
  • Abstract Number: 1318 • 2016 ACR/ARHP Annual Meeting

    Profile of Macrophage-Derived Cytokines and Chemokines of Patients with Chikungunya-Induced Chronic Arthralgia/Arthritis

    Idali Martinez1, Edwin Lopez1, Zelma L. Rios1 and Luis M. Vilá2, 1Department of Microbiology, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, 2Department of Medicine, Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico

    Background/Purpose: Chikungunya virus (CHIKV) caused a large epidemic in Puerto Rico in 2014 with more than 30,000 reported cases. Many of the affected individuals developed…
  • Abstract Number: 2156 • 2016 ACR/ARHP Annual Meeting

    IL-6 and TNF-α Modulate Expressions of Cell Cycle Regulators of Rheumatoid Arthritis Fibroblast-like Synoviocytes

    Kenta Kaneshiro1, Teppei Hashimoto2, Kohsuke Yoshida1, Ayako Nakai1, Naonori Hashimoto1, Kohjin Suzuki1, Koto Uchida1, Yoshiko Kawasaki2, Natsuko Nakagawa3, Nao Shibanuma4, Yoshitada Sakai5 and Akira Hashiramoto6, 1Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan, 2Department of Rheumatology, Kobe Kaisei Hospital, Kobe, Japan, 3Department of Orthopaedic Surgery, Konan-Kakogawa Hospital, Kakogawa, Japan, 4Departmant of Orthopaedic Surgery, Kobe Kaisei Hospital, Kobe, Japan, 5Division of Rehabilitation Medicine, Kobe University Graduate School of Medicine, Kobe, Japan, 6Department of Biophysics, Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan

    Background/Purpose:   Iinterleukin(IL)-6 and tumor necrosis factor(TNF)-α play important roles in the pathogenesis of RA, however, it remains unclear how they affect or modulate the…
  • Abstract Number: 1327 • 2016 ACR/ARHP Annual Meeting

    Patients with Chikungunya Fever Have Increased Serum Levels of Proinflamatory Cytokines 

    Andrea Dantas1, Claudia Marques2, Nara Cavalcanti1, Aline Ranzolin1, Laurindo Rocha Jr3, Carolina Andrade1, Paula Toche1, Mariana Luna4, Kamila Vilar5, Pablo Cardoso6, Michelly Pereira7, Moacyr Rêgo7, Angela Duarte8 and Maira Pitta6, 1Hospital das Clínicas, Universidade Federal de Pernambuco, Recife, Brazil, 2Hospital das Clínicas, Universidade Federal de Pernambuco, Recife - PE, Brazil, 3Rheumatology, Instituto de Medicina Integral Professor Fernando Figueira - IMIP, Recife, Brazil, 4Universidade Federal de Pernambuco, Recife, Brazil, 5Departamento de bioquímica, Laboratório de Imunomodulação e Novas Abordagens Terapêuticas - UFPE, Recife, Brazil, 6Departamento de Bioquímica, Laboratório de Imunomodulação e Novas Abordagens Terapêuticas - UFPE, Recife, Brazil, 7Bioquimica, Laboratório de Imunomodulação e Novas Abordagens Terapêuticas - UFPE, Recife, Brazil, 8Av. Prof. Moraes Rego, s/n, Av. Prof. Moraes Rego, s/n, Recife, Brazil

    Background/Purpose:  Chikungunya fever (CHIK) is an arboviral disease characterized by sudden onset of fever and incapacitating polyarthralgia. Some patients develop chronic articular symptoms but the…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 38
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology